Gene · 7083
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. | Cancer Res | 2023 | 36318118 | PubTator, text mining | PubMed |
| RNA m6 A methylation in cancer. | Mol Oncol | 2023 | 36260366 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications. | Bioact Mater | 2023 | 36185736 | PubTator, text mining | PubMed |
| Non-canonical roles of apoptotic and DNA double-strand break repair factors in mediating cellular response to ionizing radiation. | Int J Radiat Biol | 2023 | 34187285 | PubTator, text mining | PubMed |
| The value of metabolic LncRNAs in predicting prognosis and immunotherapy efficacy of gastric cancer. | Front Oncol | 2022 | 36686809 | PubTator, text mining | PubMed |
| Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma. | Front Genet | 2022 | 36685912 | PubTator, text mining | PubMed |
| A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review. | Int J Mol Sci | 2022 | 36613852 | PubTator, text mining | PubMed |
| Roles and Mechanisms of Long Non-Coding RNAs in Breast Cancer. | Int J Mol Sci | 2022 | 36613528 | PubTator, text mining | PubMed |
| Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy. | Front Pharmacol | 2022 | 36569326 | PubTator, text mining | PubMed |
| Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis. | Int J Mol Sci | 2022 | 36555470 | PubTator, text mining | PubMed |
| Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study. | Ann Transl Med | 2022 | 36544650 | PubTator, text mining | PubMed |
| DNA-enabled fluorescent-based nanosensors monitoring tumor-related RNA toward advanced cancer diagnosis: A review. | Front Bioeng Biotechnol | 2022 | 36532593 | PubTator, text mining | PubMed |
| Automated Optimized Synthesis of [18F]FLT Using Non-Basic Phase-Transfer Catalyst with Reduced Precursor Amount. | Molecules | 2022 | 36500417 | PubTator, text mining | PubMed |
| Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. | Int J Mol Sci | 2022 | 36498861 | PubTator, text mining | PubMed |
| Unbalanced Glutamine Partitioning between CD8T Cells and Cancer Cells Accompanied by Immune Cell Dysfunction in Hepatocellular Carcinoma. | Cells | 2022 | 36497182 | PubTator, text mining | PubMed |
| circPLIN2 promotes clear cell renal cell carcinoma progression by binding IGF2BP proteins and miR-199a-3p. | Cell Death Dis | 2022 | 36494341 | PubTator, text mining | PubMed |
| Machine Learning Modeling of Protein-intrinsic Features Predicts Tractability of Targeted Protein Degradation. | Genomics Proteomics Bioinformatics | 2022 | 36494034 | PubTator, text mining | PubMed |
| Effectively computing transition patterns with privacy-preserved trajectory datasets. | PLoS One | 2022 | 36490250 | PubTator, text mining | PubMed |
| A treatment-refractory aggressive MDS-MLD with multiple highly complex chromosome 5 intrachromosomal rearrangements: a case report. | Mol Cytogenet | 2022 | 36474285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7083/papers?page=19